Recombinant human endostatin (Endostar)

DRUG2 trials

Sponsors

Shanghai Chest Hospital, Qianfoshan Hospital

Conditions

Lung CancerNon-Small-Cell Lung Cancer

Phase 2

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer With Negative Driver Gene: a Multicenter, Single-Arm Trial

Qianfoshan HospitalNon-Small-Cell Lung Cancer

Start: 2021-02-01End: 2024-04-01Target: 100Updated: 2022-10-12

Phase 4

Rh-Endostatin Combined With CCRT(50 Gy) Followed by Durvalumab Maintenance for the Treatment of Specific Phase III NSCLC

Shanghai Chest HospitalLung Cancer

Start: 2020-12-01End: 2023-08-31Target: 97Updated: 2020-11-03

Related Papers

The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer

Investigational New Drugs2024-05-031 citations